Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples